HER3 Expression and PIK3CA Mutational Status Predict Pathological Response of Neoadjuvant Therapy in HER2 Positive Breast Cancer Patients
{{output}}
Purpose: The main purpose of this study is to explore the predictive value of HER3 expression level and PIK3CA mutation for the efficacy of neoadjuvant therapy in HER2 positive breast cancer patients. ... ...
